NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

介入性無線電生物學(IVR)的全球市場預測(2020年∼2026年)

Global Interventional Radiology Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 1008088
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
介入性無線電生物學(IVR)的全球市場預測(2020年∼2026年) Global Interventional Radiology Market 2020-2026
出版日期: 2021年04月23日內容資訊: 英文
簡介

全球介入性無線電生物學(IVR)的市場規模,從2021年到2027年的預測期間內預計以6.5%的年複合成長率大幅度擴大。介入性無線電生物學,是導引幾乎全部的內臟器官系統的各種疾病診斷和治療用微創外科手術的技術。促進市場成長的主要原因,是老年人口增加與栓塞症和癌症等慢性疾病增加。再加上各種介入性無線電生物學組織的合作伴隨的微創技術等的先進技術的產品增加趨勢和必要性,在預測期間內也促進市場成長。還有印度,中國,巴西等新興經濟國的放射治療相關意識高漲,對介入性無線電生物學市場成長也有所貢獻。因為這些國家,癌症患者數增加,放射線技術的必要性高漲,促進市場成長。

本報告提供全球介入性無線電生物學(IVR)市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 法規

第3章 競爭情形

  • 主要的策略分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最新趨勢
  • 主要的策略分析
  • 對主要企業的COVID-19的影響

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各產品市場
    • 血管造影術系統
    • 電腦斷層掃描
    • 透視系統
    • MRI系統
    • 超音波影像系統
    • 其他(成像導管導管導引線,C臂)
  • 各應用領域市場
    • 心臟病
    • 腫瘤學
    • 泌尿科及腎臟科
    • 胃腸病學
    • 其他(整形外科,婦產科)
  • 各治療市場
    • 血管造影術
    • 血管成形術
    • 切片檢查和引流
    • 栓塞術
    • 血栓溶解
    • 椎體成形術
    • 腎瘺造設術
    • 其他次序(輸卵管再通車,膽囊切除術)

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Agfa-Gevaert Group
  • Analogic Corp.
  • Carestream Health, Inc.
  • Esaote S.p.A.
  • FUJIFILM Holdings
  • GE Healthcare
  • 日立醫療保健、 製造業
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC.
  • Samsung Medison
  • Siemens AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • 島津製作所
  • Siemens Healthcare
  • Teleflex Inc.
  • 東芝MedicalSystems
  • Canon Medical Systems
  • Trivitron Healthcare
目錄
Product Code: OMR2023381

Global Interventional Radiology Market Size, Share & Trends Analysis Report by Diagnostic Modalities (Angiography Systems, CT Scan, Fluoroscopy Systems, MRI Systems, Ultrasound Imaging Systems and Others (Imaging Catheter Guidewires, C-ARM)), By Application (Cardiology, Oncology, Urology & Nephrology, Gastroenterology and Others (Orthopedics, Gynecology)), By Procedure (Angiography, Angioplasty, Biopsy and Drainage, Embolization, Thrombolysis, Vertebroplasty, Nephrostomy, Other Procedure) Forecast Period 2021-2027

The global interventional radiology market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period (2021-2027). Interventional radiology is a technique that guides minimally invasive surgical procedures for the diagnosis and treatment of various diseases in nearly every organ system. The major factors that are augmenting the growth of the market include the rising geriatric population and increasing chronic diseases such as embolization and cancer. Besides, the rising trend and need for technologically advanced products such as minimally invasive technologies along with the collaboration of various interventional radiology organizations are some other factors that are estimated to fuel the growth of the market during the forecast period. Furthermore, the rise in awareness concerning radiology treatment in emerging economies such as India, China, Brazil, among more is also contributing towards the growth of the interventional radiology market. In these countries, the patient pool for cancer is increasing which is resulting in an increased need for radiology techniques, boosting the market growth.

On the other hand, certain factors that are negatively affecting the growth of the market include low adoption of digital technology-based systems, implementation of stringent regulatory procedures for approval, and high-cost treatment. Although, the emergence of cloud-based medical imaging and the increasing need for low pain and risk-free radiology techniques over open surgery procedures are some of the opportunities to capitalize on, during the forecast period.

Impact of COVID-19 on the Interventional Radiology Market

The interventional radiology market is expected to grow significantly with barely affected by the COVID-19 outbreak. The demand for CT scan, Chest X-ray, and ultrasound has enabled the continuous positive growth during the outbreak of COVID-19. The CT scan, Chest X-ray, and ultrasound has been used as diagnostic tools to analyze the pneumonia infection in the lungs apart from laboratory test (RT-PCR). Further, availability of point of care imaging solution has enabled healthcare profession to diagnose the condition of the COVID-19 patient without hospital visit. As imaging tools can be helpful in fighting against pandemic, the players are focused on developing wireless handheld imaging tools to reduce the spread of infection and enable easy diagnosis. For instance, Butterfly iQ, a new generation of handheld ultrasound devices developed by Butterfly Network, allows faster assessment of pulmonary symptoms of the disease, while minimizing the spread of COVID-19 by reducing the need to move patients and equipment during the treatment process.

Segmental Outlook

The market is segmented based on product, application, and procedure. By product, the market is segmented into angiography systems, CT scan, fluoroscopy systems, MRI systems, ultrasound imaging systems, and others (imaging catheter guidewires, C-ARM). Based on the application segment, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and others (orthopedics and gynecology). Based on the procedure segment, the market is segmented into angiography, angioplasty, biopsy and drainage, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures (fallopian tube recanalization, cholecystectomy).

Source: OMR Global

Among the procedure segment, the angiography system category holds a major market share in 2020. The angiography system market growth is driven by an increase in patient safety and ensured faster recovery provided by these systems. It also aids in eliminating the need for cost-intensive invasive surgeries due to which, medical professionals are increasingly adopting minimally invasive surgical procedures over conventional open procedures. Some of the major angiography system treatment providers include Koninklijke Philips N.V., Siemens Healthcare, Canon Medical Systems Inc., among more. Further, the rising prevalence of cardiovascular diseases is expected to contribute to the segment growth.

Regional Outlooks

Geographically, the global interventional radiology market is analyzed into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to be the leading region for the global interventional radiology market. Technological advancements and the rising geriatric population are the major factors driving the growth of the market in North America. While, Asia-Pacific is estimated to be the fastest-growing market during the forecast period, due to the rise in healthcare expenditures and increasing prevalence of chronic diseases as well as population increase in emerging countries including China and India.

Global Interventional Radiology Market Growth, by Region 2021-2027

Source: OMR Global

Market Players Outlook

Key players operating in the interventional radiology market include Siemens Healthcare, Medtronic plc, GE Healthcare, Koninklijke Philips N.V., Agfa-Gevaert Group, Fujifilm Holdings Corp., Carestream Health, and Hologic Corp, among more. To survive in the market these players adopt different marketing strategies such as a merger, acquisitions, product launch, and geographical expansion so on. For Instance, in August 2019, Philips completed the acquisition of Carestream Health's Healthcare Information Systems business in 26 of the 38 countries in which it operates. Carestream HCIS's cloud-enabled enterprise imaging platform expanded Philips' enterprise diagnostic informatics solutions, including productivity enhancement, imaging data management, and advanced visualization and analysis. In addition, in August 2020, Philips acquired Intact Vascular for $275M to expand its minimally invasive therapy options for peripheral artery disease with the Tack endovascular system.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global interventional radiology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Interventional Radiology Industry
  • Recovery Scenario of Global Interventional Radiology Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Interventional Radiography Market by Product
    • 5.1.1. Angiography Systems
    • 5.1.2. CT Scan
    • 5.1.3. Fluoroscopy Systems
    • 5.1.4. MRI Systems
    • 5.1.5. Ultrasound Imaging Systems
    • 5.1.6. Others (Imaging Catheter Guidewires, C-Arm)
  • 5.2. Global Interventional Radiography Market by Application
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Urology & Nephrology
    • 5.2.4. Gastroenterology
    • 5.2.5. Others (Orthopedics, Gynecology)
  • 5.3. Global Interventional Radiography Market by Procedure
    • 5.3.1. Angiography
    • 5.3.2. Angioplasty
    • 5.3.3. Biopsy and Drainage
    • 5.3.4. Embolization
    • 5.3.5. Thrombolysis
    • 5.3.6. Vertebroplasty
    • 5.3.7. Nephrostomy
    • 5.3.8. Other Procedure (Fallopian Tube Recanalization, Cholecystectomy)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Agfa-Gevaert Group
  • 7.2. Analogic Corp.
  • 7.3. Carestream Health, Inc.
  • 7.4. Esaote S.p.A.
  • 7.5. Fujifilm Holdings Corp.
  • 7.6. GE Healthcare
  • 7.7. Hitachi Medical Corp.
  • 7.8. Hologic, Inc.
  • 7.9. Koninklijke Philips N.V.
  • 7.10. Medtronic PLC.
  • 7.11. Samsung Medison
  • 7.12. Siemens AG
  • 7.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 7.14. Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • 7.15. Shimazdu Corp.
  • 7.16. Siemens Healthcare
  • 7.17. Teleflex Inc.
  • 7.18. Toshiba Medical Systems Corp.
  • 7.19. Canon Medical Systems Inc.
  • 7.20. Trivitron Healthcare

LIST OF TABLES

  • 1. GLOBAL INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS, BY PRODUCT 2020-2027 ($ MILLION)
  • 2. GLOBAL MRI SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL CT SCANNER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL ANGIOGRAPHY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL FLUOROSCOPY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY APPLICATION 2020-2027($ MILLION)
  • 9. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 10. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 11. GLOBAL UROLOGY & NEPHROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 12. GLOBAL GASTROENTEROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 13. GLOBAL OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 14. GLOBAL INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PROCEDURE 2020-2027($ MILLION)
  • 15. GLOBAL ANGIOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL ANGIOPLASTY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL BIOPSY AND DRIANAGE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL EMBOLIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL THROMBOLYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 20. GLOBAL VERTEBROPLASTY MARKET RESEARCH AND ANALYSIS BY REGION,2020-2027 ($ MILLION)
  • 21. GLOBAL NEPHROSTOMY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 22. GLOBAL OTHER PROCEDURES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 24. NORTH AMERICAN INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 25. NORTH AMERICAN INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 26. EUROPEAN INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 27. EUROPEAN INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 28. EUROPEAN INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 33. REST OF THE WORLD INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD INTERVENTIONAL RADIOGRAPHY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INTERVENTIONAL RADIOLOGY MARKET SHARE BY PRODUCT, 2020 VS 2027(%)
  • 2. GLOBAL INTERVENTIONAL RADIOLOGY MARKET SHARE BY APPLICATION, 2020 VS 2027(%)
  • 3. GLOBAL INTERVENTIONAL RADIOLOGY MARKET SHARE BY PROCEDURES, 2020 VS 2027(%)
  • 4. GLOBAL MRI SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 5. GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 6. GLOBAL CT SCANNER MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 7. GLOBAL ANGIOGRAPHY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 8. GLOBAL FLUOROSCOPY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 9. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 10. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 11. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 12. GLOBAL UROLOGY & NEPHROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 13. GLOBAL GASTROENTEROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 14. GLOBAL OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 15. GLOBAL ANGIOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 16. GLOBAL ANGIOPLASTY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 17. GLOBAL BIOPSY AND DRIANAGE MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 18. GLOBAL EMBOLIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 19. GLOBAL THROMBOLYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 20. GLOBAL VERTEBROPLASTY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 21. GLOBAL NEPHROSTOMY MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 22. GLOBAL OTHER PROCEDURES MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027(%)
  • 23. US INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. CANADA INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. UK INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. FRANCE INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. GERMANY INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. ITALY INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. SPAIN INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. ROE INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. ASIA PACIFIC INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. INDIA INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. CHINA INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. JAPAN INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. SOUTH KOREA INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 36. REST OF ASIA-PACIFIC INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD INTERVENTIONAL RADIOLOGY MARKET SIZE, 2020-2027 ($ MILLION)